
Video Player is loading.
PARP Inhibitors for Maintenance Therapy in Ovarian Cancer – PARP inhibitors have improved progression-free survival.
The Top 10 Medical Innovations for 2020, in order of anticipated importance, were released at the annual Medical Innovation Summit, organized by Cleveland Clinic Innovations, the development and commercialization arm of Cleveland Clinic.
Latest from Today's Medical Developments
- ASU, University of Michigan launch manufacturing research center
- HORN unveils innovative threading solutions at EMO 2025
- #70 Manufacturing Matters - CUI Crash Course with Smithers
- Precision matters
- Talking toolholding and workholding over lunch
- How accurate strength predictions will shape the future of lightweight materials
- Unpacking electric vehicle market turbulence
- TRANSOR launches new website